United Therap Drug Patent Portfolio

United Therap's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

United Therap News

United Therapeutics Corporation vs. Liquidia Technologies, Inc. | Robins Kaplan LLP - JDSupra

27 Jan, 2026

Merck's Q3 Results for Non-Oncology Medications: Anticipations Ahead - The Globe and Mail

24 Oct, 2025

Merck's Q3 Results for Non-Oncology Medications: Anticipations Ahead - Yahoo Finance

24 Oct, 2025

Merck's Q3 Results for Non-Oncology Medications: Anticipations - TradingView

24 Oct, 2025

See More